Skip to main content
Premium Trial:

Request an Annual Quote

Ivan Richards, Ian Gray, Edward McCabe

Premium

Ivan Richards has been appointed senior director of pharmacology at Sirna Therapeutics, the company said Nov. 4.

Richards comes to Sirna from Pfizer, and prior to the merger, Pharmacia, where he was a scientist, senior fellow, and discovery team leader.


Ian Gray has been appointed head of research at Paradigm Therapeutics Singapore, a new Singapore R&D subsidiary of the Cambridge, UK-based company.

Gray comes to Paradigm Therapeutics from GlaxoSmithKline, where he was manager of molecular genetics in the company’s UK genetics research division, the company said last week.


Edward McCabe has joined the board of advisors at GeneFluidics, of Monterey Park, Calif., the company said Nov. 3.

McCabe is chair of the department of pediatrics at UCLA Medical School. He is also chair of the US Department of Health and Human Services Secretary’s Advisory Committee on Genetics, Health, and Society.

GeneFluidics said it is developing nanotechnology that electrochemically senses target analytes, and performs automated sample preparation.

 

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.